Novel coronavirus disease 2019 (COVID-19): relationship between chest CT scores and laboratory parameters

• Published in: European journal of nuclear medicine and molecular imaging Vol. 47; no. 9; pp. 2083 - 2089
• Main Authors: Zhang, Bin, Zhang, Jue, Chen, Hui, Chen, Luyan, Chen, Qiuying, Li, Minmin, Chen, Zhuozhi, You, Jingjing, Yang, Ke, Zhang, Shuixing
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.08.2020; Springer Nature B.V
• Subjects: Abnormalities; Absorption; Adult; Aged; Aged, 80 and over; C-reactive protein; Cardiology; Chest; Computed tomography; Coronaviridae; Coronavirus Infections - diagnostic imaging; Coronaviruses; COVID-19; Female; Fluorescence; Humans; Imaging; Infection and inflammation; Laboratories; Lactose; Leukocytes; Lungs; Male; Medical records; Medicine; Medicine & Public Health; Middle Aged; Neutrophils; Nuclear Medicine; Oncology; Original; Original Article; Orthopedics; Pandemics; Parameters; Patients; Pneumonia, Viral - diagnostic imaging; Polymerase chain reaction; Procalcitonin; Radiography, Thoracic; Radiology; Tomography, X-Ray Computed; Viral diseases; Young Adult; COVID-19; Chest CT; Laboratory parameters

Purpose To quantify the severity of 2019 novel coronavirus disease (COVID-19) on chest CT and to determine its relationship with laboratory parameters. Methods Patients with real-time fluorescence polymerase chain reaction (RT-PCR)–confirmed COVID-19 between January 01 and February 18, 2020, were in...